PURPOSE: Evidence shows that alcohol intake causes oxidative neuronal injury and neurocognitive deficits that are distinct from the classical Wernicke-Korsakoff neuropathy. Our previous findings indicated that alcohol-elicited blood-brain barrier (BBB) damage leads to neuroinflammation and neuronal loss. The dynamic function of the BBB requires a constant supply and utilization of glucose. Here we examined whether interference of glucose uptake and transport at the endothelium by alcohol leads to BBB dysfunction and neuronal degeneration. MATERIAL AND METHODS: We tested the hypothesis in cell culture of human brain endothelial cells, neurons and alcohol intake in animal by immunofluorescence, Western blotting and glucose uptake assay methods. RESULTS: We found that decrease in glucose uptake correlates the reduction of glucose transporter protein 1 (GLUT1) in cell culture after 50 mM ethanol exposure. Decrease in GLUT1 protein levels was regulated at the translation process. In animal, chronic alcohol intake suppresses the transport of glucose into the frontal and occipital regions of the brain. This finding is validated by a marked decrease in GLUT1 protein expression in brain microvessel (the BBB). In parallel, alcohol intake impairs the BBB tight junction proteins occludin, zonula occludens-1, and claudin-5 in the brain microvessel. Permeability of sodium fluorescein and Evans Blue confirms the leakiness of the BBB. Further, depletion of trans-endothelial electrical resistance of the cell monolayer supports the disruption of BBB integrity. Administration of acetyl-L: -carnitine (a neuroprotective agent) significantly prevents the adverse effects of alcohol on glucose uptake, BBB damage and neuronal degeneration. CONCLUSION: These findings suggest that alcohol-elicited inhibition of glucose transport at the blood-brain interface leads to BBB malfunction and neurological complications.
PURPOSE: Evidence shows that alcohol intake causes oxidative neuronal injury and neurocognitive deficits that are distinct from the classical Wernicke-Korsakoff neuropathy. Our previous findings indicated that alcohol-elicited blood-brain barrier (BBB) damage leads to neuroinflammation and neuronal loss. The dynamic function of the BBB requires a constant supply and utilization of glucose. Here we examined whether interference of glucose uptake and transport at the endothelium by alcohol leads to BBB dysfunction and neuronal degeneration. MATERIAL AND METHODS: We tested the hypothesis in cell culture of human brain endothelial cells, neurons and alcohol intake in animal by immunofluorescence, Western blotting and glucose uptake assay methods. RESULTS: We found that decrease in glucose uptake correlates the reduction of glucose transporter protein 1 (GLUT1) in cell culture after 50 mM ethanol exposure. Decrease in GLUT1 protein levels was regulated at the translation process. In animal, chronic alcohol intake suppresses the transport of glucose into the frontal and occipital regions of the brain. This finding is validated by a marked decrease in GLUT1 protein expression in brain microvessel (the BBB). In parallel, alcohol intake impairs the BBB tight junction proteins occludin, zonula occludens-1, and claudin-5 in the brain microvessel. Permeability of sodium fluorescein and Evans Blue confirms the leakiness of the BBB. Further, depletion of trans-endothelial electrical resistance of the cell monolayer supports the disruption of BBB integrity. Administration of acetyl-L: -carnitine (a neuroprotective agent) significantly prevents the adverse effects of alcohol on glucose uptake, BBB damage and neuronal degeneration. CONCLUSION: These findings suggest that alcohol-elicited inhibition of glucose transport at the blood-brain interface leads to BBB malfunction and neurological complications.
Authors: Alan Cahill; Carol C Cunningham; Masayuki Adachi; Hiromasa Ishii; Shannon M Bailey; Bernard Fromenty; Adrian Davies Journal: Alcohol Clin Exp Res Date: 2002-06 Impact factor: 3.455
Authors: Y Kido; I Tamai; A Ohnari; Y Sai; T Kagami; J Nezu; H Nikaido; N Hashimoto; M Asano; A Tsuji Journal: J Neurochem Date: 2001-12 Impact factor: 5.372
Authors: Tory M Hagen; Jiankang Liu; Jens Lykkesfeldt; Carol M Wehr; Russell T Ingersoll; Vladimir Vinarsky; James C Bartholomew; Bruce N Ames Journal: Proc Natl Acad Sci U S A Date: 2002-02-19 Impact factor: 11.205
Authors: James Haorah; Servio H Ramirez; Nicholas Floreani; Santhi Gorantla; Brenda Morsey; Yuri Persidsky Journal: Free Radic Biol Med Date: 2008-09-17 Impact factor: 7.376
Authors: Caroline D Rae; Joanne E Davidson; Anthony D Maher; Benjamin D Rowlands; Mohammed A Kashem; Fatima A Nasrallah; Sundari K Rallapalli; James M Cook; Vladimir J Balcar Journal: J Neurochem Date: 2013-12-18 Impact factor: 5.372
Authors: Nora D Volkow; Sung Won Kim; Gene-Jack Wang; David Alexoff; Jean Logan; Lisa Muench; Colleen Shea; Frank Telang; Joanna S Fowler; Christopher Wong; Helene Benveniste; Dardo Tomasi Journal: Neuroimage Date: 2012-08-28 Impact factor: 6.556